Skip to main content
search
All Posts By

Ben Kemp

Membership NewsMembership News Archive

BIVDA head to Midlands for ‘Innovations against AMR’ event

As part of World Antibiotic Awareness Week (WAAW) Medilink Midlands and Cytecom hosted their annual 'Innovations against AMR' event at Warwick University. The event was designed to bring together experts and stakeholders from across the AMR landscape to share insights, showcase innovations and foster collaboration. BIVDA were represented at the event by Lucy Lehane, who was invited to participate in…
Ben Kemp
November 25, 2025
Membership NewsMembership News Archive

BIVDA responds to second COVID Inquiry report

The second report of the COVID-19 Inquiry has identified serious failings in the UK’s political governance and decision-making during the pandemic and makes 19 recommendations. Issues include chaotic leadership structures, a lack of urgency in recognising the scale of the threat, and delays in implementing restrictions. The Inquiry found that the UK’s governments were repeatedly “too little, too late”, with…
Ben Kemp
November 25, 2025
HighlightsHighlights Archive

MHRA and NHS launch new partnership to support innovation across London’s health and care system

MHRA and the NHS in London are launching a new collaborative partnership to support responsible innovation across our capital's health and care system. They envisage the creation of a London Innovation Sandbox – a safe, structured space where health system innovators can collaborate with regulators. By working together in a collaborative environment, the MHRA aim to accelerate innovations that address…
Ben Kemp
November 25, 2025
HighlightsHighlights Archive

Government must make urgent changes to restore confidence of UK life sciences sector, Committee warns

Dame Chi Onwurah, Chair of the Science, Innovation and Technology Committee, has written to the Health Secretary, Wes Streeting, to warn that urgent changes to the processes behind pricing and uptake of new medicines and health technologies are needed to restore confidence in the UK’s life sciences sector. This letter comes after the Committee held evidence sessions in September and October…
Ben Kemp
November 25, 2025
Membership NewsMembership News Archive

Attend the UKHSA ‘The Future of Diagnostics’ event on Monday 1st December

As part of London Bio-Innovation Week, join UKHSA and Canary Wharf Life Sciences for insight and networking from leading diagnostics experts, including BIVDA's AMR expert Dr Jayne Ellis. The Future of Diagnostics with UKHSA and Canary Wharf Life Sciences UKHSA have teamed up with Canary Wharf Life Sciences to deliver this One Nucleus/BioInnovation Week Fringe event on diagnostics. The COVID-19…
Ben Kemp
November 25, 2025
Membership NewsMembership News Archive

Men’s Health Strategy unveiled by UK Government

The Government has launched England's first ever Men's Health Strategy today. Key takeaways for the diagnostics sector are commitments to: Invest £3 million over 3 years, starting in April 2026, into community-based men’s health programmes, designed to reach those most at risk and least likely to engage with traditional services. Explore opportunities to allow men to order relevant tests at…
Ben Kemp
November 25, 2025
Membership NewsMembership News Archive

DBT Webinars: China Medtech Unlocked: Opportunities for UK Life Sciences businesses

The UK Government's China Medtech Unlocked: Opportunities for UK Life Sciences Businesses webinar series is now online for registration. China offers significant commercial potential, but navigating its complexities requires informed strategies and strong networks. This series aims to help businesses with the critical insights, practical tools, and expert connections necessary for success. Upcoming Webinars in the Series: 05 Dec: Overview & Regulation…
Ben Kemp
November 24, 2025
Membership NewsMembership News Archive

BIVDA Spotlight: MeMed

This week, we are spotlighting MeMed, whose 15-minute test which distinguishes between a bacterial or viral infection is currently being trialled by the NHS. Who We Are MeMed is a global leader in host-immune response diagnostics. Our mission is to translate the immune system’s complex signals into simple, actionable insights that empower clinicians to make better infection-management decisions, helping to…
Ben Kemp
November 24, 2025
Close Menu